The effect of corn trypsin inhibitor, anti-tissue factor pathway inhibitor antibodies and phospholipids on microvesicle-associated thrombin generation in patients with pancreatic cancer and healthy controls

PLoS ONE

Volumn 12, Issue 9, 2017, Pages

  Hellum, Marit ^a,b   Franco Lie, Isabel ^b   Øvstebø, Reidun ^b   Hauge, Truls ^a,b   Henriksson, Carola E ^a,b  

^a UNIVERSITY OF OSLO   (Norway)

^b OSLO UNIVERSITY HOSPITAL   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY; CORN TRYPSIN INHIBITOR; PHOSPHATIDYLSERINE; PHOSPHOLIPID; THROMBOPLASTIN; TISSUE FACTOR PATHWAY INHIBITOR ANTIBODY; TRYPSIN INHIBITOR; UNCLASSIFIED DRUG; LIPOPROTEIN; LIPOPROTEIN-ASSOCIATED COAGULATION INHIBITOR; PLANT PROTEIN; THROMBIN; TRYPSIN INHIBITOR, ZEA MAYS;

ADULT; ARTICLE; ASSAY; CALIBRATED AUTOMATED THROMBOGRAM; CANCER PATIENT; CELL ISOLATION; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN CELL; MALE; MEMBRANE MICROPARTICLE; MIDDLE AGED; PANCREAS CANCER; PLASMA; POOLED NORMAL PLASMA; PROSPECTIVE STUDY; THROMBIN TIME; ZYMUPHEN MP ACTIVITY ASSAY; AGED; COMPLICATION; DRUG EFFECTS; IMMUNOLOGY; METABOLISM; NORMAL HUMAN; PANCREAS TUMOR;

AGED; ANTIBODIES; CELL-DERIVED MICROPARTICLES; FEMALE; HEALTHY VOLUNTEERS; HUMANS; LIPOPROTEINS; MALE; MIDDLE AGED; PANCREATIC NEOPLASMS; PHOSPHATIDYLSERINES; PHOSPHOLIPIDS; PLANT PROTEINS; THROMBIN; THROMBOPLASTIN;

EID: 85029484649     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0184579     Document Type: Article

References (45)

1. Pabinger I, Thaler J, Ay C. Biomarkers for prediction of venous thromboembolism in cancer. Blood. 2013; 122(12):2011–8. Epub 2013/08/03. https://doi.org/10.1182/blood-2013-04-460147 PMID: 23908470
2. Campello E, Spiezia L, Radu CM, Simioni P. Microparticles as biomarkers of venous thromboembolic events. Biomark Med. 2016; 10(7):743–55. Epub 2016/06/25. https://doi.org/10.2217/bmm-2015-0063PMID: 27338783
3. Gyorgy B, Szabo TG, Pasztoi M, Pal Z, Misjak P, Aradi B, et al. Membrane vesicles, current state-of-the-art: emerging role of extracellular vesicles. Cell Mol Life Sci. 2011; 68(16):2667–88. Epub 2011/05/ 12. https://doi.org/10.1007/s00018-011-0689-3 PMID: 21560073
4. Freyssinet JM, Toti F. Formation of procoagulant microparticles and properties. Thromb Res. 2010; 125 Suppl 1:S46–8. Epub 2010/02/16. https://doi.org/10.1016/j.thromres.2010.01.036 PMID: 20153515
5. Morel O, Jesel L, Freyssinet JM, Toti F. Cellular mechanisms underlying the formation of circulating microparticles. Arterioscler Thromb Vasc Biol. 2011; 31(1):15–26. Epub 2010/12/17. https://doi.org/10.1161/ATVBAHA.109.200956 PMID: 21160064
6. Rapaport SI, Rao LV. Initiation and regulation of tissue factor-dependent blood coagulation. Arterioscler Thromb. 1992; 12(10):1111–21. Epub 1992/10/01. PMID: 1390583
7. Han X, Guo B, Li Y, Zhu B. Tissue factor in tumor microenvironment: a systematic review. J Hematol Oncol. 2014; 7:54. Epub 2014/08/03. https://doi.org/10.1186/s13045-014-0054-8 PMID: 25084809
8. Khorana AA, Ahrendt SA, Ryan CK, Francis CW, Hruban RH, Hu YC, et al. Tissue factor expression, angiogenesis, and thrombosis in pancreatic cancer. Clin Cancer Res. 2007; 13(10):2870–5. Epub 2007/05/17. https://doi.org/10.1158/1078-0432.CCR-06-2351 PMID: 17504985
9. Seto S, Onodera H, Kaido T, Yoshikawa A, Ishigami S, Arii S, et al. Tissue factor expression in human colorectal carcinoma: correlation with hepatic metastasis and impact on prognosis. Cancer. 2000; 88 (2):295–301. Epub 2000/01/21. PMID: 10640960
10. Ueno T, Toi M, Koike M, Nakamura S, Tominaga T. Tissue factor expression in breast cancer tissues: its correlation with prognosis and plasma concentration. Br J Cancer. 2000; 83(2):164–70. Epub 2000/ 07/20. https://doi.org/10.1054/bjoc.2000.1272 PMID: 10901365
11. Rautou PE, Mackman N. Microvesicles as risk markers for venous thrombosis. Expert Rev Hematol. 2013; 6(1):91–101. Epub 2013/02/05. https://doi.org/10.1586/ehm.12.74 PMID: 23373784
12. Khorana AA, Fine RL. Pancreatic cancer and thromboembolic disease. Lancet Oncol. 2004; 5(11):655–63. Epub 2004/11/04. https://doi.org/10.1016/S1470-2045(04)01606-7 PMID: 15522652
13. Thaler J, Ay C, Mackman N, Bertina RM, Kaider A, Marosi C, et al. Microparticle-associated tissue factor activity, venous thromboembolism and mortality in pancreatic, gastric, colorectal and brain cancer patients. J Thromb Haemost. 2012; 10(7):1363–70. Epub 2012/04/24. https://doi.org/10.1111/j.15387836.2012.04754.x PMID: 22520016
14. Bharthuar A, Khorana AA, Hutson A, Wang JG, Key NS, Mackman N, et al. Circulating microparticle tissue factor, thromboembolism and survival in pancreaticobiliary cancers. Thromb Res. 2013; 132 (2):180–4. Epub 2013/07/17. https://doi.org/10.1016/j.thromres.2013.06.026 PMID: 23856554
15. Thaler J, Ay C, Mackman N, Metz-Schimmerl S, Stift J, Kaider A, et al. Microparticle-associated tissue factor activity in patients with pancreatic cancer: correlation with clinicopathological features. Eur J Clin Invest. 2013; 43(3):277–85. Epub 2013/02/13. https://doi.org/10.1111/eci.12042 PMID: 23398637
16. Tesselaar ME, Romijn FP, Van Der Linden IK, Prins FA, Bertina RM, Osanto S. Microparticle-associated tissue factor activity: a link between cancer and thrombosis? J Thromb Haemost. 2007; 5(3):520–7. Epub 2006/12/15. https://doi.org/10.1111/j.1538-7836.2007.02369.x PMID: 17166244
17. van Doormaal F, Kleinjan A, Berckmans RJ, Mackman N, Manly D, Kamphuisen PW, et al. Coagulation activation and microparticle-associated coagulant activity in cancer patients. An exploratory prospective study. Thromb Haemost. 2012; 108(1):160–5. Epub 2012/04/27. https://doi.org/10.1160/TH12-02-0099PMID: 22535219
18. Khorana AA, Francis CW, Menzies KE, Wang JG, Hyrien O, Hathcock J, et al. Plasma tissue factor may be predictive of venous thromboembolism in pancreatic cancer. J Thromb Haemost. 2008; 6 (11):1983–5. Epub 2008/09/18. https://doi.org/10.1111/j.1538-7836.2008.03156.x PMID: 18795992
19. Pabinger I, Posch F. Flamethrowers: blood cells and cancer thrombosis risk. Hematology Am Soc Hematol Educ Program. 2014; 2014(1):410–7. Epub 2015/02/20. https://doi.org/10.1182/asheducation-2014.1.410 PMID: 25696887
20. Owens AP 3rd, Mackman N. Microparticles in hemostasis and thrombosis. Circ Res. 2011; 108 (10):1284–97. Epub 2011/05/14. https://doi.org/10.1161/CIRCRESAHA.110.233056 PMID: 21566224
21. Mooberry MJ, Key NS. Microparticle analysis in disorders of hemostasis and thrombosis. Cytometry Part A: the journal of the International Society for Analytical Cytology. 2015. Epub 2015/02/24. https://doi.org/10.1002/cyto.a.22647 PMID: 25704723
22. Key NS, Mackman N. Tissue factor and its measurement in whole blood, plasma, and microparticles. Semin Thromb Hemost. 2010; 36(8):865–75. Epub 2010/11/05. https://doi.org/10.1055/s-0030-1267040 PMID: 21049387
23. Hemker HC, Giesen P, Al Dieri R, Regnault V, de Smedt E, Wagenvoord R, et al. Calibrated automated thrombin generation measurement in clotting plasma. Pathophysiol Haemost Thromb. 2003; 33(1):4–15. Epub 2003/07/11. https://doi.org/71636 PMID: 12853707
24. Ay C, Dunkler D, Simanek R, Thaler J, Koder S, Marosi C, et al. Prediction of venous thromboembolism in patients with cancer by measuring thrombin generation: results from the Vienna Cancer and Thrombosis Study. J Clin Oncol. 2011; 29(15):2099–103. Epub 2011/04/06. https://doi.org/10.1200/JCO.2010.32.8294 PMID: 21464402
25. Bidot L, Jy W, Bidot C Jr., Jimenez JJ, Fontana V, Horstman LL, et al. Microparticle-mediated thrombin generation assay: increased activity in patients with recurrent thrombosis. J Thromb Haemost. 2008; 6 (6):913–9. Epub 2008/03/28. https://doi.org/10.1111/j.1538-7836.2008.02963.x PMID: 18363818
26. Aleman MM, Gardiner C, Harrison P, Wolberg AS. Differential contributions of monocyte- and platelet-derived microparticles towards thrombin generation and fibrin formation and stability. J Thromb Haemost. 2011; 9(11):2251–61. Epub 2011/09/03. https://doi.org/10.1111/j.1538-7836.2011.04488.xPMID: 21883880
27. Gheldof D, Hardij J, Cecchet F, Chatelain B, Dogne JM, Mullier F. Thrombin generation assay and transmission electron microscopy: a useful combination to study tissue factor-bearing microvesicles. Journal of extracellular vesicles. 2013;2. https://doi.org/10.3402/jev.v2i0.19728 PMID: 24009889
28. Luddington R, Baglin T. Clinical measurement of thrombin generation by calibrated automated thrombo-graphy requires contact factor inhibition. J Thromb Haemost. 2004; 2(11):1954–9. Epub 2004/11/20. https://doi.org/10.1111/j.1538-7836.2004.00964.x PMID: 15550027
29. Gheldof D, Mullier F, Chatelain B, Dogne JM, Chatelain C. Inhibition of tissue factor pathway inhibitor increases the sensitivity of thrombin generation assay to procoagulant microvesicles. Blood Coagul Fibrinolysis. 2013; 24(5):567–72. https://doi.org/10.1097/MBC.0b013e328360a56e PMID: 23807485
30. Brodin E, Appelbom H, Osterud B, Hilden I, Petersen LC, Hansen JB. Regulation of thrombin generation by TFPI in plasma without and with heparin. Transl Res. 2009; 153(3):124–31. Epub 2009/02/17. https://doi.org/10.1016/j.trsl.2008.12.004 PMID: 19218095
31. Wood JP, Ellery PE, Maroney SA, Mast AE. Biology of tissue factor pathway inhibitor. Blood. 2014; 123 (19):2934–43. Epub 2014/03/13. https://doi.org/10.1182/blood-2013-11-512764 PMID: 24620349
32. Keuren JF, Magdeleyns EJ, Govers-Riemslag JW, Lindhout T, Curvers J. Effects of storage-induced platelet microparticles on the initiation and propagation phase of blood coagulation. Br J Haematol. 2006; 134(3):307–13. Epub 2006/07/20. https://doi.org/10.1111/j.1365-2141.2006.06167.x PMID: 16848773
33. Brummel-Ziedins KE, Vossen CY, Butenas S, Mann KG, Rosendaal FR. Thrombin generation profiles in deep venous thrombosis. J Thromb Haemost. 2005; 3(11):2497–505. Epub 2005/10/26. https://doi.org/10.1111/j.1538-7836.2005.01584.x PMID: 16241948
34. Hellum M, Ovstebo R, Brusletto BS, Berg JP, Brandtzaeg P, Henriksson CE. Microparticle-associated tissue factor activity correlates with plasma levels of bacterial lipopolysaccharides in meningococcal septic shock. Thromb Res. 2014; 133(3):507–14. Epub 2014/01/16. https://doi.org/10.1016/j.thromres.2013.12.031 PMID: 24423888
35. Kluft C, Meijer P. External quality assessment for thrombin generation tests: an exploration. Semin Thromb Hemost. 2010; 36(7):791–6. Epub 2010/10/28. https://doi.org/10.1055/s-0030-1265296 PMID: 20979000
36. Van Der Meijden PE, Van Schilfgaarde M, Van Oerle R, Renne T, ten Cate H, Spronk HM. Platelet- and erythrocyte-derived microparticles trigger thrombin generation via factor XIIa. J Thromb Haemost. 2012; 10(7):1355–62. Epub 2012/04/28. https://doi.org/10.1111/j.1538-7836.2012.04758.x PMID: 22537188
37. Nickel KF, Ronquist G, Langer F, Labberton L, Fuchs TA, Bokemeyer C, et al. The polyphosphate-factor XII pathway drives coagulation in prostate cancer-associated thrombosis. Blood. 2015; 126 (11):1379–89. Epub 2015/07/15. https://doi.org/10.1182/blood-2015-01-622811 PMID: 26153520
38. Ramstrom S. Clotting time analysis of citrated blood samples is strongly affected by the tube used for blood sampling. Blood Coagul Fibrinolysis. 2005; 16(6):447–52. Epub 2005/08/12. PMID: 16093737
39. Boknas N, Faxalv L, Lindahl TL, Ramstrom S. Contact activation: important to consider when measuring the contribution of tissue factor-bearing microparticles to thrombin generation using phospholipid-containing reagents. J Thromb Haemost. 2014; 12(4):515–8. Epub 2014/01/11. https://doi.org/10.1111/jth.12503 PMID: 24405583
40. Thomassen MC, Heinzmann AC, Herfs L, Hartmann R, Dockal M, Scheiflinger F, et al. Tissue factor-independent inhibition of thrombin generation by tissue factor pathway inhibitor-alpha. J Thromb Haemost. 2015; 13(1):92–100. Epub 2014/10/29. https://doi.org/10.1111/jth.12766 PMID: 25348176
41. Wood JP, Bunce MW, Maroney SA, Tracy PB, Camire RM, Mast AE. Tissue factor pathway inhibitor-alpha inhibits prothrombinase during the initiation of blood coagulation. Proc Natl Acad Sci U S A. 2013; 110(44):17838–43. Epub 2013/10/16. https://doi.org/10.1073/pnas.1310444110 PMID: 24127605
42. Thaler J, Koder S, Kornek G, Pabinger I, Ay C. Microparticle-associated tissue factor activity in patients with metastatic pancreatic cancer and its effect on fibrin clot formation. Transl Res. 2014; 163(2):145–50. Epub 2013/08/27. https://doi.org/10.1016/j.trsl.2013.06.009 PMID: 23973167
43. Thaler J, Ay C, Weinstabl H, Dunkler D, Simanek R, Vormittag R, et al. Circulating procoagulant microparticles in cancer patients. Ann Hematol. 2011; 90(4):447–53. Epub 2010/10/29. https://doi.org/10.1007/s00277-010-1111-1 PMID: 20981426
44. Tesselaar ME, Romijn FP, van der Linden IK, Bertina RM, Osanto S. Microparticle-associated tissue factor activity in cancer patients with and without thrombosis. J Thromb Haemost. 2009; 7(8):1421–3. Epub 2009/06/09. https://doi.org/10.1111/j.1538-7836.2009.03504.x PMID: 19500241
45. Yuana Y, Boing AN, Grootemaat AE, van der Pol E, Hau CM, Cizmar P, et al. Handling and storage of human body fluids for analysis of extracellular vesicles. Journal of extracellular vesicles. 2015; 4:29260. Epub 2015/11/14. https://doi.org/10.3402/jev.v4.29260 PMID: 26563735